Ss. Avtushenko et al., CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF THE EMULSION FORM OF INACTIVATED INFLUENZA VACCINE DELIVERED BY ORAL IMMUNIZATION, Journal of biotechnology, 44(1-3), 1996, pp. 21-28
Prophylaxis of human respiratory diseases caused by influenza viruses
is actually a problem of infectious pathology because of their wide pr
evalence. In our investigations, safety, reactogenicity and immunologi
cal activity of the orally administered emulsion-inactivated influenza
vaccine prepared from influenza virus strains of types A(H1N1), A(H3N
2) and B have been studied. Clinical studies of the emulsion-inactivat
ed influenza vaccine on volunteers has shown its safety and nonreactog
enicity. The orally administered vaccine did not cause weak, middle or
strong general or local reactions including clinical, biochemical, ha
emotological and immunological reactions. The emulsion-inactivated vac
cine has high immunological activity and induces reliable increases in
the level of secretory immunoglobulin A to influenza viruses A and B
in protective titers in nasal secretions and saliva of volunteers afte
r one oral administration. The obtained results indicate the expedienc
y of further investigation and improvement of inactivated influenza va
ccine for oral administration.